Prescribers with restrictions
Based on data from TPP Alberta, CPSA can impose prescribing conditions on physicians that restrict their prescriptive authority under certain situations. These listings and conditions are below.
Pharmacists can contact TPP Alberta using the contact form at the bottom of this page for guidance if questions arise or advice is required in specific circumstances.
Any prescribing condition effective before March 1st, 2021 does not include Antibiotics.
Physicians
Adams, James (Jim)
Date effective: Aug. 15, 2024
Restrictions:
Type 1 and Type 2 medications monitored by the Alberta Tracked Prescription Program except for stimulants for the treatment of ADD and ADHD, benzodiazapines, antibiotics, Z class drugs, Gabapentin and Pregabalin.
Restriction:
Restricted from prescribing all Type 1 and Type 2 medications monitored by the Alberta Tracked Prescription Program, excluding antibiotics. Exception: Alberta TPP medications, Type 1 and Type 2, prescriptions that included refills in the original prescription that were initiated prior to this restriction shall only be permitted until July 28, 2024. As of July 29, 2024, no exceptions shall apply and no prescription refills shall be permitted.
Alshigagi, Emadalden
Date effective: May 1, 2024
Barrow, John Lincoln
Date effective: May 31, 2024
Ben Milud Jalutha, Ben
Date effective: May 21, 2024
Restriction:
Restricted from prescribing OAT medications for the management of Opioid Use Disorder (with the exception of Buprenorphine/Naloxone).
Restriction:
No new Type 1 or Type 2 opioid prescriptions (may only refill chronic opioid prescriptions for current patients).
Restriction:
Restricted from prescribing all Type 1 and Type 2 medications monitored by the Alberta Tracked Prescription Program, excluding antibiotics. Exception: Alberta TPP medications, Type 1 and Type 2, prescriptions that included refills in the original prescription that were initiated prior to this restriction shall only be permitted until July 28, 2024. As of July 29, 2024, no exceptions shall apply and no prescription refills shall be permitted.
Collett, Franklin Dean
Date effective: Nov. 29, 2019
Dulai, Gurjeet Singh
Date effective: March 27, 2020
Restrictions:
Restricted from prescribing TPP Alberta (Type 1) medications except for hospital inpatients, patients in a long-term care facility and immediate administration in the emergency department. Restricted from dispensing or administering TPP Alberta (Type 2) medications.
Han, William (Wei)
Date effective: Jan. 15, 2023
Hauptman, Robert
Date effective: July 8, 2024
Restrictions:
Restricted from prescribing all Type 1 and Type 2 medications monitored by the Alberta Tracked Prescription Program (TPP), and cannabinoids. Excludes antimicrobials.
Restrictions:
Restricted from prescribing All Alberta TPP medications Type 1, and Type 2, with the exclusion of antibiotics, gabapentinoids, stimulants and Orexin antagonists. Permitted to prescribe Alberta TPP medications Type 2 containing codeine or tramadol for the treatment of acute, episodic pain for up to fourteen (14) days per three-month period for patients already in Dr. Hauptman's practice panel.
Kordyban, Michael
Date effective: Dec. 2, 2015
Restrictions:
Voluntarily surrenders all TPP Alberta pads under his control and shall not request resumption of prescribing of medications requiring the use of a TPP Alberta pad, in any manner.
Lavallee, Melvyn
Date effective: March 22, 2023
Restrictions:
Type 1 and Type 2 medications monitored by the Alberta Tracked Prescription Program except for antibiotics; gabapentin, pregabalin, sustained release stimulants with a documented diagnosis of attention deficit disorder; and benzodiazepines for the treatment of epilepsy.
Lopez, Roehl
Date effective: March 2, 2023
Restrictions:
Restricted from prescribing Tramadol and any other Type 1 and Type 2 medications monitored by the Alberta Tracked Prescribing Program except for gabapentin, Pregabalin, antibiotics and benzodiazepines for the treatment of patients with epilepsy.
McAlpine, Brian Douglas
Date effective: March 11, 2022
Restrictions:
Restricted from prescribing TPP (Tracked Prescription Program) Alberta Type 1 and Type 2 medications (not including antibiotics) except for emergencies, in which case the prescription shall be for no more than a 3-day supply.
McMahon, Alan
Date effective: April 22, 2020
Restrictions:
Restricted from prescribing TPP Alberta Type 1, Type 2 (not including antibiotics) and all cannabinoids.
McPeak, Brian K.
Date effective: Aug. 28, 2019
McKennitt, Daniel William
Date effective: Oct. 25, 2022
Restrictions:
Prescribing of Type 1 TPP Alberta medications restricted to inpatient facilities.
Restrictions:
Prescribing of medications monitored by TPP Alberta (Type 1 and 2 medications) including Tramadol, with the exception of antibiotics.
Mentz, Helena Johanna
Date effective: May 2, 2024
Restrictions:
Prescribing restrictions apply. May maintain currently active prescriptions for Alberta TPP Type 1 and Type 2 medications initiated prior to this restriction, but is otherwise restricted from prescribing all Alberta TPP Type 1 and Type 2 medications with the exclusion of stimulants, gabapentinoids, and antibiotics.
Mitchell, Oluwatomi (Tomi)
Date effective: Aug. 16, 2018
Restrictions:
Restricted from prescribing Opioids.
Mohamed, Ataher S
Date effective: May 2, 2024
Restrictions:
Prescribing restrictions apply. Permitted to prescribe Alberta TPP Type 1 and Type 2 medications under the monitoring of and only in accordance with the direction from the CPSA Physician Prescribing Practices Program.
Oyama, Sonnie
Date effective: Feb. 8, 2022
Restrictions:
Type 1 and Type 2 opioid and benzodiazepine medications monitored by the Tracked Prescription Program (TPP), includes all methadone and cannabinoids but does not apply to antimicrobials, Z-drugs and stimulants tracked by the TPP.
Rosenstock, Carl
Date effective: Oct. 8, 2020
Restrictions:
Restricted to prescribing TPP Alberta medications to patients attached to my practice as of October 1, 2020. Restricted to prescribing opioids only to existing patients with a diagnosis of malignancy. Restricted to prescribing benzodiazepines only to existing patients with diagnoses of seizure disorders or malignancy.
Swart, Johan
Date effective: Dec. 14, 2017
Restrictions:
Restricted from prescribing Type 1 Medications as per the TPP Alberta program.
Werkman, Isabella
Date effective: March 1, 2020
Restrictions:
Restricted from prescribing opioid medications, methadone, Suboxone and cannabinoids.